Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
01/2001
01/30/2001US6180087 Tunable indocyanine dyes for biomedical applications
01/30/2001US6180085 Useful for optical tomographic, endoscopic, photoacoustic and sonofluoresence applications for detection and treatment of tumors and other abnormalities
01/30/2001US6179883 2-imino-2,3-dihydro-1H-indole derivatives for dyeing keratin fibers
01/25/2001WO2001005791A2 NEW PROCESS FOR THE PREPARATION OF N-(1,1-DIMETHYLETHYL)-4-[[5'-ETHOXY-4-cis-[2-(4-MORFOLINO)ETHOXY]-2'-OXOSPIRO[CYCLOHEXAN-1,3'-[H]INDOL]-1'(2'H)-yl]-SULFONYL]-3-METHOXYBENZAMIDE AND ITS SALTS
01/25/2001WO2001005765A1 Cyclic amides and imides having selective antagonist activity at alpha-1d adrenergic receptor
01/25/2001WO2001005761A1 sPLA2 INHIBITORS
01/25/2001WO2001005760A2 New process for the preparation of spiro [(4-cyclohexanone)-[3h]indol]-2'[1'h]-one derivatives
01/25/2001WO2001005759A2 Process for the preparation of spiro-[cis-4-(beta-hydroxyethyloxy)cyclohexane-(3h) indol)-2'(1'h)-one derivatives
01/25/2001WO2001005758A2 Indoles and indazoles for the treatment of migraine
01/25/2001DE19934433A1 New N-(indolyl-carbonyl)-N'-ethyl-piperazine derivatives, are 5-HT-2A receptor antagonists useful e.g. for treating schizophrenia, depression, Parkinson's disease, Alzheimer's disease or anorexia
01/25/2001DE19934321A1 New N-phenyl-naphthalenesulfonamide derivatives are antiviral agents especially useful for treating cytomegalovirus infections
01/25/2001DE19934283A1 Agent for coloring fibres, especially for temporary coloration of the hair, made by mixing prior to use of one component containing an enamine compound and another component containing at least one carbonyl compound
01/25/2001CA2379208A1 Spla2 inhibitors
01/25/2001CA2378047A1 Heterocyclic compounds for the treatment of migraine
01/24/2001EP1070705A1 Indole derivatives
01/24/2001EP1070703A1 Cyclobutene derivatives
01/24/2001EP1070051A1 Process for the production of r-(+)-6- carboxamido- 3-n- methylamino- 1,2,3,4- tetrahydrocarbazole
01/24/2001EP1070050A1 N-aryloxyethyl-indoly-alkylamines for the treatment of depression (5-ht1a receptor active agents)
01/24/2001EP1070048A1 Calcilytic compounds
01/24/2001EP1070046A1 Propanolamine derivatives
01/24/2001EP0712389B1 Therapeutic compound - fatty acid conjugates
01/24/2001EP0559687B1 2-aminocinnamic acid esters
01/24/2001CN1281436A N-Benzyl-3-indenylacetamides derivatives for treating neoplasia
01/24/2001CN1281429A Novel aryloxy-alkyl-dialkylamines
01/24/2001CN1281334A Method for treating Alzheimer's disease
01/24/2001CN1061069C Purification of indigo
01/24/2001CN1061034C Tricyclic indole-2-carboxylic acid derivatives
01/23/2001US6177570 Reaction of dicarboxylic anhydride with an amine in the presence of a tertiary amine.
01/23/2001US6177466 Matrix metalloproteinase inhibitors
01/23/2001US6177440 Substituted tricyclics
01/23/2001US6177426 Morpholino-N-ethyl ester prodrugs of indole sPLA2 inhibitors
01/23/2001US6177401 Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
01/23/2001CA2197272C Pro-drugs of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6- chloro-1,3-dihydro-2h-indol-2-one
01/22/2001CA2312203A1 Cyclobutene derivatives, their preparation and their therapeutic uses
01/18/2001WO2001004173A1 Process for the polymerisation of cycloolefins and polymerisable cycloolefins
01/18/2001WO2001004092A1 Process for the preparation of tricyclic amino alcohol derivatives
01/18/2001WO2001003684A2 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
01/18/2001DE19933313A1 Agent for coloring fibres, especially for temporary coloration of the hair, made by mixing prior to use of one component containing an enamine compound and another component containing at least one carbonyl compound
01/18/2001CA2377760A1 Process for the preparation of tricyclic amino alcohol derivatives
01/17/2001EP1069125A2 Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs, a process for their preparation and their use as medicaments
01/17/2001EP1069111A1 Indole derivatives with antiviral activity
01/17/2001EP1069110A1 Sulfonamide derivatives
01/17/2001EP1068865A1 Use of 4,6-dimethoxy-indole 2 carboxylic acid or derivatives thereof for seborrhea treatment
01/17/2001EP1068858A1 Use of 4,6-dimethoxyindole-2-carboxylic acid for stimulating or inducing hair growth and/or arresting hair loss
01/17/2001EP1068306A1 Pentaerythritol lipid derivatives
01/17/2001EP1068199A2 N-aryloxyethyl-indoly-alkylamines for the treatment of depression
01/17/2001EP1068193A1 Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d 4? receptor antagonists
01/17/2001EP1068184A1 N-aryloxyethylamine derivatives for the treatment of depression
01/17/2001EP1068178A1 NON-PEPTIDE GnRH AGENTS
01/17/2001EP1067950A1 Neo-tryptophan
01/17/2001EP1067925A1 Antidiabetic agents
01/17/2001CN1280578A Bis-quaternary ammonium derivatives as neuromuscular relaxants
01/17/2001CN1280566A Method of synthesis of pyrrole amides
01/17/2001CN1280561A Amidocarboxylic acid derivatives
01/17/2001CN1280560A Adamantane derivatives
01/17/2001CN1060761C New aryl (alkyl) propylamides, process for preparing them and pharmaceutical compositions containing them
01/16/2001US6175021 Human non-pancreatic secretory phospholipase a2 (spla2); inhibits release of arachidonic acid to treat septic shock; ((3-(2-amino-1,2-dioxoethyl)-2-methyl-1-(phenylmethyl)-1h-indol-4 -yl)oxylacetic acid, for example
01/16/2001US6175020 2-(((alk)oxy or amino)carbonylmethyl),9-((protected)aminomethyl)-1-azaspiro(4.4)nonane compounds, useful as template for constructing synthetic receptors and as intermediates in the synthesis of enzyme inhibitors
01/16/2001US6175015 Fused indolecarboxamides: dopamine receptor subtype specific ligands
01/16/2001US6175014 Process for the preparation of lactam derivatives
01/16/2001US6174924 Treating nerve cell death comprising administering to a subject exhibiting symptoms of nerve cell death or susceptible to nerve cell death a substituted guanidine compound
01/16/2001US6174889 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
01/16/2001US6174883 3-substituted-2-oxindoles derivatives
01/16/2001US6174839 As herbicide
01/16/2001CA2314539A1 Use of 4,6-dimethoxy-indole 2-carboxylic acid or its derivatives for the treatment of seborrhoea
01/11/2001WO2001002403A1 METHOD FOR PREPARING SUBSTITUTED [1,4]DIAZEPINO[6,7,1-hi]INDOL-4-ONES
01/11/2001WO2001002388A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications
01/11/2001WO2001002369A2 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
01/11/2001WO2001002368A1 N-heterocyclic derivatives with neuronal activity
01/11/2001WO2001002355A2 Indole synthesis
01/11/2001WO2000059904A3 Compounds and methods to treat cardiac failure and other disorders
01/11/2001CA2376707A1 Process for the preparation of substituted ¬1,4|diazepino¬6,7,1-hi|indol-4-ones
01/11/2001CA2376657A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications
01/10/2001EP1066290A1 PYRROLO[1,2-a]PYRAZINE sPLA 2 INHIBITOR
01/10/2001EP1066283A2 Substituted indolealkanoic acids
01/10/2001EP1066258A1 Aryl phenyl substituted cyclic ketoenols
01/10/2001EP1066257A2 Heterocylic classes of compounds for the modulating tyrosine protein kinase
01/10/2001CN1279617A Combination of an aldose reductase inhibitor and a glycogen phosphorglase inhibitor
01/10/2001CN1060472C Hydroxamic acid derivatives with tricylic substitution, their preparing methods, medicines containing them and uses thereof
01/09/2001US6172261 Biosynthesis using chain extension
01/09/2001US6172255 Alkoxy-alkyl-substituted 1-H-3-aryl-pyrrolidine-2,4-diones used as herbicides and pesticides
01/09/2001US6172113 Bicyclic amino derivatives and PGD2 antagonist containing the same
01/09/2001US6172108 Hydrazide compounds
01/09/2001US6172100 Administering aminated 1-benzyl-2-phenylindole derivatives; benzylation
01/09/2001US6172099 Tricyclic compounds having saturated rings and medicinal compositions containing the same
01/09/2001US6172084 Quinoline-indole antimicrobial agents, uses and compositions related thereto
01/09/2001US6172082 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
01/09/2001US6172073 Benzimidazolyloxy alkanamines as serotonin reuptake inhibitors; nicotine and tobacco withdrawal; psychological, eating, brain, gastrointestinal, sleep, and sexual disorders
01/09/2001US6172072 Heterocyclically substituted benzamides and their use in fighting diseases
01/09/2001US6172057 Antiinflammatory agents; antiarthritic agents; antitumor agents
01/04/2001WO2001000658A1 C-terminal modified (n-substituted)-2-indolylcarbonyldipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
01/04/2001WO2001000576A1 Indole and indazole urea-peptoids as thrombin receptor antagonists
01/04/2001WO2001000206A1 Vla-4 inhibitor compounds
01/04/2001WO2001000197A2 Methods of treating fungal infections with inhibitors of nad synthetase enzyme
01/04/2001CA2376892A1 Methods of treating fungal infections with inhibitors of nad synthetase enzyme
01/04/2001CA2369308A1 Vla-4 inhibitor compounds
01/04/2001CA2365341A1 C-terminal modified (n-substituted)-2-indolylcarbonyldipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
01/03/2001EP1065204A1 Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents and as COX-2 inhibitors
01/03/2001EP1065203A2 Heterocyclic compounds as retinoic acid receptor antagonists
01/03/2001EP1064941A1 Use of melatoninergic ligands for obtaining pharmaceutical compositions for the prevention or the treatment of gastrointestinal pathologies